#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14890	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2033	725.9	0	.	n	.	0	C451T	SNP	451	451	C	681	681	T	856	T,C	799,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14890	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2033	725.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	920	C	849	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3453	792.8	0	.	n	.	0	T695C	SNP	695	695	T	1011	1011	C	833	C,T	781,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3453	792.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2287	2287	C	912	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3453	792.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2361	2361	A	853	A	809	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3453	792.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2913	2913	C	841	C,A	788,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3453	792.8	0	HET	.	.	.	A1638G	.	1638	1638	A	1954	1954	A	885	A,G	639,190	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2242	folP	855	855	100.0	folP.l15.c4.ctg.1	1613	138.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1103	1105	AGC	235;237;235	A;G;C	222;222;220	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3507	161.8	1	SNP	p	S91F	1	.	.	271	273	TTC	652	654	TTC	200;196;196	T;T;C	184;182;183	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3507	161.8	1	SNP	p	D95G	1	.	.	283	285	GGC	664	666	GGC	199;198;200	G;G,A;C	181;181,1;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5682	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3507	161.8	1	SNP	p	G95N	0	.	.	283	285	GGC	664	666	GGC	199;198;200	G;G,A;C	181;181,1;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1830	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1267	143.5	1	SNP	p	G45D	0	.	.	133	135	GGC	458	460	GGC	263;262;261	G;G;C	245;244;241	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	920	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1047	87.6	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	203	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2980	176.4	1	SNP	p	D86N	0	.	.	256	258	GAC	605	607	GAC	207;206;206	G;A;C	182;178;184	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2980	176.4	1	SNP	p	R87W	0	.	.	259	261	CGT	608	610	CGT	203;202;202	C;G;T	183;182;179	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2980	176.4	1	SNP	p	R87I	0	.	.	259	261	CGT	608	610	CGT	203;202;202	C;G;T	183;182;179	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2980	176.4	1	SNP	p	S87R	1	.	.	259	261	CGT	608	610	CGT	203;202;202	C;G;T	183;182;179	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2980	176.4	1	SNP	p	S88P	0	.	.	262	264	TCC	611	613	TCC	202;200;200	T;C;C	181;183;183	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4360	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2883	150.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1653	1655	GGC	233;232;233	G;G;C,G	214;212;213,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1314	1316	GCC	246;243;243	G;C;C	235;232;232	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1317	1319	ATG	247;248;249	A;T;G	235;238;238	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1329	1331	ACC	239;239;240	A;C;C	227;232;232	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1329	1331	ACC	239;239;240	A;C;C	227;232;232	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1830	1832	ACC	240;242;242	A;C;C	217;226;225	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1884	1886	GCG	228;227;224	G;C;G	217;217;212	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1884	1886	GCG	228;227;224	G;C;G	217;217;212	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2007	2009	GGT	203;199;197	G;G;T	185;182;177	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2016	2018	AGC	182;179;180	A;G,T;C	164;159,1;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4380	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2601	167.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2034	2036	CCG	142;147;145	C,G;C,A;G	103,4;109,1;112	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5896	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3041	193.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1584	1586	CCG	216;218;215	C;C;G	194;203;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2330	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1896	122.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	560	560	C	164	C	152	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2868	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1571	181.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	935	937	AGA	270;268;266	A;G;A	249;247;248	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2868	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1571	181.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	956	958	GGT	266;265;269	G;G;T	248;248;250	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2868	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1571	181.2	1	SNP	p	G120K	1	.	.	358	360	AAG	665	667	AAG	248;250;247	A;A;G	233;236;226	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2868	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1571	181.2	1	SNP	p	N121D	0	.	.	361	363	AAC	668	670	AAC	248;248;249	A;A;C	233;233;235	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2868	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1571	181.2	1	SNP	p	A121N	1	.	.	361	363	AAC	668	670	AAC	248;248;249	A;A;C	233;233;235	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10508	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4900	213.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1000	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	999	99.8	1	SNP	p	V57M	1	.	.	169	171	ATG	502	504	ATG	209;207;209	A;T;G	200;197;197	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
